Keywords
Last Name

Sydney Rosen, MPA

TitleResearch Professor
InstitutionBoston University School of Public Health
DepartmentGlobal Health
Address801 Massachusetts Ave Crosstown Center
Boston MA 02118
Phone(617) 414-1273
ORCID ORCID Icon0000-0002-6560-2964
Other Positions
TitleCenter Faculty Member
InstitutionBoston University School of Public Health
DepartmentCenter for Global Health & Development

 Awards and Honors

Start-EndDescription
2003Harvard Business Review: McKinsey Award
 Research Expertise & Professional Interests
Sydney Rosen, M.P.A., is a Research Professor in the Department of Global Health and the Center for Global Health & Development of the Boston University School of Public Health and the co-director of the Health Economics and Epidemiology Research Office (HE2RO) of the Wits Health Consortium at the University of the Witwatersrand in Johannesburg, South Africa. In collaboration with HE2RO and colleagues at BUSPH, she leads an interdisciplinary team that is carrying out a set of studies on the effectiveness, costs, and benefits of HIV/AIDS care and treatment interventions. She has also worked on other applied economics projects in the Department, including research on the economics of tuberculosis, antimicrobial resistance, malaria prevention and treatment, and air pollution. Her technical training is in public policy analysis and applied economics. She came to BUSPH in 2001 from the Health Office of the former Harvard Institute for International Development (HIID). Before joining the staff of the Health Office, she managed a set of HIID environmental policy projects in the former Soviet Union. She is also the co-founder and former executive director of WorldTeach, Inc., a nonprofit organization that places volunteer teachers in developing countries. She holds a B.A. from Harvard University and a master's degree from the Kennedy School of Government at Harvard.

 NIH RePORTER Grants
 Self-Described Keywords
  • Health economics
  • HIV
  • South Africa
  • Antiretroviral therapy
  • Cost-effectiveness analysis
 Publications
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
List All   |   Timeline
  1. Long LC, Rosen SB, Brennan A, Moyo F, Sauls C, Evans D, Modi SL, Sanne I, Fox MP. Treatment Outcomes and Costs of Providing Antiretroviral Therapy at a Primary Health Clinic versus a Hospital-Based HIV Clinic in South Africa. PLoS One. 2016; 11(12):e0168118. PMID: 27942005.
    View in: PubMed
  2. Berhanu R, Schnippel K, Mohr E, Hirasen K, Evans D, Rosen S, Sanne I. Early Outcomes Of Decentralized Care for Rifampicin-Resistant Tuberculosis in Johannesburg, South Africa: An Observational Cohort Study. PLoS One. 2016; 11(11):e0164974. PMID: 27812140.
    View in: PubMed
  3. Gama E, Madan J, Langley I, Girma M, Evans D, Rosen S, Squire SB. Economic evaluation of a shortened standardised treatment regimen of antituberculosis drugs for patients with multidrug-resistant tuberculosis (STREAM): study protocol. BMJ Open. 2016 Oct 17; 6(10):e014386. PMID: 27798041.
    View in: PubMed
  4. Budgell EP, Evans D, Schnippel K, Ive P, Long L, Rosen S. Outcomes of treatment of drug-susceptible tuberculosis at public sector primary healthcare clinics in Johannesburg, South Africa: A retrospective cohort study. S Afr Med J. 2016 Sep 05; 106(10):1002-1009. PMID: 27725021.
    View in: PubMed
  5. Rosen S, Fox MP, Larson BA, Sow PS, Ehrenkranz PD, Venter F, Manabe YC, Kaplan J. Accelerating the Uptake and Timing of Antiretroviral Therapy Initiation in Sub-Saharan Africa: An Operations Research Agenda. PLoS Med. 2016 Aug; 13(8):e1002106. PMID: 27505444.
    View in: PubMed
  6. Fox MP, Rosen S, Geldsetzer P, Bärnighausen T, Negussie E, Beanland R. Interventions to improve the rate or timing of initiation of antiretroviral therapy for HIV in sub-Saharan Africa: meta-analyses of effectiveness. J Int AIDS Soc. 2016; 19(1):20888. PMID: 27507249.
    View in: PubMed
  7. Rosen S, Maskew M, Fox MP, Nyoni C, Mongwenyana C, Malete G, Sanne I, Bokaba D, Sauls C, Rohr J, Long L. Initiating Antiretroviral Therapy for HIV at a Patient's First Clinic Visit: The RapIT Randomized Controlled Trial. PLoS Med. 2016 May; 13(5):e1002015. PMID: 27163694.
    View in: PubMed
  8. Long LC, Fox MP, Sauls C, Evans D, Sanne I, Rosen SB. The High Cost of HIV-Positive Inpatient Care at an Urban Hospital in Johannesburg, South Africa. PLoS One. 2016; 11(2):e0148546. PMID: 26885977.
    View in: PubMed
  9. Bor J, Rosen S, Chimbindi N, Haber N, Herbst K, Mutevedzi T, Tanser F, Pillay D, Bärnighausen T. Mass HIV Treatment and Sex Disparities in Life Expectancy: Demographic Surveillance in Rural South Africa. PLoS Med. 2015 Nov; 12(11):e1001905; discussion e1001905. PMID: 26599699.
    View in: PubMed
  10. Fox MP, Rosen S. Retention of Adult Patients on Antiretroviral Therapy in Low- and Middle-Income Countries: Systematic Review and Meta-analysis 2008-2013. J Acquir Immune Defic Syndr. 2015 May 1; 69(1):98-108. PMID: 25942461.
    View in: PubMed
  11. Fox MP, Rosen S. Systematic review of retention of pediatric patients on HIV treatment in low and middle-income countries 2008-2013. AIDS. 2015 Feb 20; 29(4):493-502. PMID: 25565496.
    View in: PubMed
  12. Marseille E, Larson B, Kazi DS, Kahn JG, Rosen S. Thresholds for the cost-effectiveness of interventions: alternative approaches. Bull World Health Organ. 2015 Feb 01; 93(2):118-24. PMID: 25883405.
    View in: PubMed
  13. Scott CA, Iyer HS, McCoy K, Moyo C, Long L, Larson BA, Rosen S. Retention in care, resource utilization, and costs for adults receiving antiretroviral therapy in Zambia: a retrospective cohort study. BMC Public Health. 2014; 14:296. PMID: 24684772.
    View in: PubMed
  14. Iyer HS, Scott CA, Lembela Bwalya D, Meyer-Rath G, Moyo C, Bolton Moore C, Larson BA, Rosen S. Resource Utilization and Costs of Care prior to ART Initiation for Pediatric Patients in Zambia. AIDS Res Treat. 2014; 2014:235483. PMID: 24711925.
    View in: PubMed
  15. Rosen S, Larson B, Rohr J, Sanne I, Mongwenyana C, Brennan AT, Galárraga O. Effect of antiretroviral therapy on patients' economic well being: five-year follow-up. AIDS. 2014 Jan 28; 28(3):417-24. PMID: 24076660.
    View in: PubMed
  16. Scott CA, Iyer HS, Lembela Bwalya D, Bweupe M, Rosen SB, Scott N, Larson BA. Uptake, outcomes, and costs of antenatal, well-baby, and prevention of mother-to-child transmission of HIV services under routine care conditions in Zambia. PLoS One. 2013; 8(8):e72444. PMID: 24015245.
    View in: PubMed
  17. Larson BA, Schnippel K, Brennan A, Long L, Xulu T, Maotoe T, Rosen S, Sanne I, Fox MP. Same-Day CD4 Testing to Improve Uptake of HIV Care and Treatment in South Africa: Point-of-Care Is Not Enough. AIDS Res Treat. 2013; 2013:941493. PMID: 23956850.
    View in: PubMed
  18. Schnippel K, Long L, Meyer-Rath G, Sanne I, Rosen S, Stevens W. Impact and costs of algorithms for the diagnosis of adults with pulmonary tuberculosis in South Africa. S Afr Med J. 2013 Jul; 103(7):436. PMID: 23946950.
    View in: PubMed
  19. Scott CA, Iyer H, Bwalya DL, McCoy K, Meyer-Rath G, Moyo C, Bolton-Moore C, Larson B, Rosen S. Retention in care and outpatient costs for children receiving antiretroviral therapy in Zambia: a retrospective cohort analysis. PLoS One. 2013; 8(6):e67910. PMID: 23840788.
    View in: PubMed
  20. Meyer-Rath G, Brennan AT, Fox MP, Modisenyane T, Tshabangu N, Mohapi L, Rosen S, Martinson N. Rates and cost of hospitalization before and after initiation of antiretroviral therapy in urban and rural settings in South Africa. J Acquir Immune Defic Syndr. 2013 Mar 1; 62(3):322-328. PMID: 23187948.
    View in: PubMed
  21. Schnippel K, Meyer-Rath G, Long L, Stevens WS, Sanne I, Rosen S. Diagnosing Xpert MTB/RIF negative TB: impact and cost of alternative algorithms for South Africa. S Afr Med J. 2013 Feb; 103(2):101-6. PMID: 23374320.
    View in: PubMed
  22. Meyer-Rath G, Brennan A, Long L, Ndibongo B, Technau K, Moultrie H, Fairlie L, Coovadia A, Rosen S. Cost and outcomes of paediatric antiretroviral treatment in South Africa. AIDS. 2013 Jan 14; 27(2):243-50. PMID: 23014517.
    View in: PubMed
  23. Larson BA, Fox MP, Bii M, Rosen S, Rohr J, Shaffer D, Sawe F, Wasunna M, Simon JL. Antiretroviral therapy, labor productivity, and sex: a longitudinal cohort study of tea pluckers in Kenya. AIDS. 2013 Jan 2; 27(1):115-23. PMID: 23014516.
    View in: PubMed
  24. Larson BA, Bii M, Henly-Thomas S, McCoy K, Sawe F, Shaffer D, Rosen S. ART treatment costs and retention in care in Kenya: a cohort study in three rural outpatient clinics. J Int AIDS Soc. 2013; 16:18026. PMID: 23305696.
    View in: PubMed
  25. Schnippel K, Rosen S, Shearer K, Martinson N, Long L, Sanne I, Variava E. Costs of inpatient treatment for multi-drug-resistant tuberculosis in South Africa. Trop Med Int Health. 2013 Jan; 18(1):109-16. PMID: 23170876.
    View in: PubMed
  26. Larson BA, Schnippel K, Ndibongo B, Xulu T, Brennan A, Long L, Fox MP, Rosen S. Rapid point-of-care CD4 testing at mobile HIV testing sites to increase linkage to care: an evaluation of a pilot program in South Africa. J Acquir Immune Defic Syndr. 2012 Oct 1; 61(2):e13-7. PMID: 22659650.
    View in: PubMed
  27. Fox MP, Larson B, Rosen S. Defining retention and attrition in pre-antiretroviral HIV care: proposals based on experience in Africa. Trop Med Int Health. 2012 Oct; 17(10):1235-44. PMID: 22863075.
    View in: PubMed
  28. Thirumurthy H, Galárraga O, Larson B, Rosen S. HIV treatment produces economic returns through increased work and education, and warrants continued US support. Health Aff (Millwood). 2012 Jul; 31(7):1470-7. PMID: 22778336.
    View in: PubMed
  29. Schnippel K, Meyer-Rath G, Long L, MacLeod W, Sanne I, Stevens WS, Rosen S. Scaling up Xpert MTB/RIF technology: the costs of laboratory- vs. clinic-based roll-out in South Africa. Trop Med Int Health. 2012 Sep; 17(9):1142-51. PMID: 22686606.
    View in: PubMed
  30. Meyer-Rath G, Schnippel K, Long L, MacLeod W, Sanne I, Stevens W, Pillay S, Pillay Y, Rosen S. The impact and cost of scaling up GeneXpert MTB/RIF in South Africa. PLoS One. 2012; 7(5):e36966. PMID: 22693561.
    View in: PubMed
  31. Larson B, Schnippel K, Ndibongo B, Long L, Fox MP, Rosen S. How to estimate the cost of point-of-care CD4 testing in program settings: an example using the Alere Pima Analyzer in South Africa. PLoS One. 2012; 7(4):e35444. PMID: 22532854.
    View in: PubMed
  32. Long L, Brennan A, Fox MP, Ndibongo B, Jaffray I, Sanne I, Rosen S. Treatment outcomes and cost-effectiveness of shifting management of stable ART patients to nurses in South Africa: an observational cohort. PLoS Med. 2011 Jul; 8(7):e1001055. PMID: 21811402.
    View in: PubMed
  33. Rosen S, Fox MP. Retention in HIV care between testing and treatment in sub-Saharan Africa: a systematic review. PLoS Med. 2011 Jul; 8(7):e1001056. PMID: 21811403.
    View in: PubMed
  34. Rosen S, Long L, Sanne I, Stevens WS, Fox MP. The net cost of incorporating resistance testing into HIV/AIDS treatment in South Africa: a Markov model with primary data. J Int AIDS Soc. 2011; 14:24. PMID: 21575155.
    View in: PubMed
  35. Rosen S, Larson B, Brennan A, Long L, Fox M, Mongwenyana C, Ketlhapile M, Sanne I. Economic outcomes of patients receiving antiretroviral therapy for HIV/AIDS in South Africa are sustained through three years on treatment. PLoS One. 2010; 5(9):e12731. PMID: 20856821.
    View in: PubMed
  36. Harries AD, Zachariah R, Lawn SD, Rosen S. Strategies to improve patient retention on antiretroviral therapy in sub-Saharan Africa. Trop Med Int Health. 2010 Jun; 15 Suppl 1:70-5. PMID: 20586963.
    View in: PubMed
  37. Rosen S, Ketlhapile M. Cost of using a patient tracer to reduce loss to follow-up and ascertain patient status in a large antiretroviral therapy program in Johannesburg, South Africa. Trop Med Int Health. 2010 Jun; 15 Suppl 1:98-104. PMID: 20586967.
    View in: PubMed
  38. Fox MP, Rosen S. Patient retention in antiretroviral therapy programs up to three years on treatment in sub-Saharan Africa, 2007-2009: systematic review. Trop Med Int Health. 2010 Jun; 15 Suppl 1:1-15. PMID: 20586956.
    View in: PubMed
  39. Larson BA, Brennan A, McNamara L, Long L, Rosen S, Sanne I, Fox MP. Early loss to follow up after enrolment in pre-ART care at a large public clinic in Johannesburg, South Africa. Trop Med Int Health. 2010 Jun; 15 Suppl 1:43-7. PMID: 20586959.
    View in: PubMed
  40. Miller CM, Ketlhapile M, Rybasack-Smith H, Rosen S. Why are antiretroviral treatment patients lost to follow-up? A qualitative study from South Africa. Trop Med Int Health. 2010 Jun; 15 Suppl 1:48-54. PMID: 20586960.
    View in: PubMed
  41. Larson BA, Brennan A, McNamara L, Long L, Rosen S, Sanne I, Fox MP. Lost opportunities to complete CD4+ lymphocyte testing among patients who tested positive for HIV in South Africa. Bull World Health Organ. 2010 Sep 1; 88(9):675-80. PMID: 20865072.
    View in: PubMed
  42. Long L, Fox M, Sanne I, Rosen S. The high cost of second-line antiretroviral therapy for HIV/AIDS in South Africa. AIDS. 2010 Mar 27; 24(6):915-9. PMID: 20042849.
    View in: PubMed
  43. Fox MP, Mazimba A, Seidenberg P, Crooks D, Sikateyo B, Rosen S. Barriers to initiation of antiretroviral treatment in rural and urban areas of Zambia: a cross-sectional study of cost, stigma, and perceptions about ART. J Int AIDS Soc. 2010; 13:8. PMID: 20205930.
    View in: PubMed
  44. Fox MP, McCoy K, Larson BA, Rosen S, Bii M, Sigei C, Shaffer D, Sawe F, Wasunna M, Simon JL. Improvements in physical wellbeing over the first two years on antiretroviral therapy in western Kenya. AIDS Care. 2010 Feb; 22(2):137-45. PMID: 20390492.
    View in: PubMed
  45. Beard J, Feeley F, Rosen S. Economic and quality of life outcomes of antiretroviral therapy for HIV/AIDS in developing countries: a systematic literature review. AIDS Care. 2009 Nov; 21(11):1343-56. PMID: 20024710.
    View in: PubMed
  46. Larson BA, Fox MP, Rosen S, Bii M, Sigei C, Shaffer D, Sawe F, McCoy K, Wasunna M, Simon JL. Do the socioeconomic impacts of antiretroviral therapy vary by gender? A longitudinal study of Kenyan agricultural worker employment outcomes. BMC Public Health. 2009; 9:240. PMID: 19604381.
    View in: PubMed
  47. Rosen S, Ketlhapile M, Sanne I, DeSilva MB. Characteristics of patients accessing care and treatment for HIV/AIDS at public and nongovernmental sites in South Africa. J Int Assoc Physicians AIDS Care (Chic). 2008 Jul-Aug; 7(4):200-7. PMID: 18626120.
    View in: PubMed
  48. Rosen S, Long L, Sanne I. The outcomes and outpatient costs of different models of antiretroviral treatment delivery in South Africa. Trop Med Int Health. 2008 Aug; 13(8):1005-15. PMID: 18631314.
    View in: PubMed
  49. Rosen S, Ketlhapile M, Sanne I, Desilva MB. Differences in normal activities, job performance and symptom prevalence between patients not yet on antiretroviral therapy and patients initiating therapy in South Africa. AIDS. 2008 Jul; 22 Suppl 1:S131-9. PMID: 18664945.
    View in: PubMed
  50. Rosen S, Long L, Fox M, Sanne I. Cost and cost-effectiveness of switching from stavudine to tenofovir in first-line antiretroviral regimens in South Africa. J Acquir Immune Defic Syndr. 2008 Jul 1; 48(3):334-44. PMID: 18545151.
    View in: PubMed
  51. Larson BA, Fox MP, Rosen S, Bii M, Sigei C, Shaffer D, Sawe F, Wasunna M, Simon JL. Early effects of antiretroviral therapy on work performance: preliminary results from a cohort study of Kenyan agricultural workers. AIDS. 2008 Jan 30; 22(3):421-5. PMID: 18195569.
    View in: PubMed
  52. Feeley F, Connelly P, Rosen S. Private sector provision and financing of AIDS treatment in Africa: current developments. Curr HIV/AIDS Rep. 2007 Dec; 4(4):192-200. PMID: 18366951.
    View in: PubMed
  53. Rosen S, Fox MP, Gill CJ. Patient retention in antiretroviral therapy programs in sub-Saharan Africa: a systematic review. PLoS Med. 2007 Oct 16; 4(10):e298. PMID: 17941716.
    View in: PubMed
  54. Rosen S, Feeley F, Connelly P, Simon J. The private sector and HIV/AIDS in Africa: taking stock of 6 years of applied research. AIDS. 2007 Jul; 21 Suppl 3:S41-51. PMID: 17666961.
    View in: PubMed
  55. Rosen S, Hamazakaza P, Feeley F, Fox M. The impact of AIDS on government service delivery: the case of the Zambia Wildlife Authority. AIDS. 2007 Jul; 21 Suppl 3:S53-9. PMID: 17666962.
    View in: PubMed
  56. Rosen S, Ketlhapile M, Sanne I, DeSilva MB. Cost to patients of obtaining treatment for HIV/AIDS in South Africa. S Afr Med J. 2007 Jul; 97(7):524-9. PMID: 17805455.
    View in: PubMed
  57. Connelly D, Veriava Y, Roberts S, Tsotetsi J, Jordan A, DeSilva E, Rosen S, DeSilva MB. Prevalence of HIV infection and median CD4 counts among health care workers in South Africa. S Afr Med J. 2007 Feb; 97(2):115-20. PMID: 17404672.
    View in: PubMed
  58. Connelly P, Rosen S. Treatment of HIV/AIDS at South Africa's largest employers: myth and reality. S Afr Med J. 2006 Feb; 96(2):128-33. PMID: 16532081.
    View in: PubMed
  59. Rosen S, Sanne I, Collier A, Simon JL. Rationing antiretroviral therapy for HIV/AIDS in Africa: choices and consequences. PLoS Med. 2005 Nov; 2(11):e303. PMID: 16159308.
    View in: PubMed
  60. Connelly P, Rosen S. Provision of antiretroviral therapy by the private sector. Lancet. 2005 Jun 4-10; 365(9475):1925-6. PMID: 15936416.
    View in: PubMed
  61. Rosen S, Sanne I, Collier A, Simon JL. Hard choices: rationing antiretroviral therapy for HIV/AIDS in Africa. Lancet. 2005 Jan 22-28; 365(9456):354-6. PMID: 15664233.
    View in: PubMed
  62. Fox MP, Rosen S, MacLeod WB, Wasunna M, Bii M, Foglia G, Simon JL. The impact of HIV/AIDS on labour productivity in Kenya. Trop Med Int Health. 2004 Mar; 9(3):318-24. PMID: 14996359.
    View in: PubMed
  63. Evian C, Fox M, MacLeod W, Slotow SJ, Rosen S. Prevalence of HIV in workforces in southern Africa, 2000-2001. S Afr Med J. 2004 Feb; 94(2):125-30. PMID: 15034992.
    View in: PubMed
  64. Rosen S, Vincent JR, MacLeod W, Fox M, Thea DM, Simon JL. The cost of HIV/AIDS to businesses in southern Africa. AIDS. 2004 Jan 23; 18(2):317-24. PMID: 15075551.
    View in: PubMed
  65. Rosen S, Simon JL. Shifting the burden: the private sector's response to the AIDS epidemic in Africa. Bull World Health Organ. 2003; 81(2):131-7. PMID: 12751421.
    View in: PubMed
  66. Rosen S, Simon J, Vincent JR, MacLeod W, Fox M, Thea DM. AIDS is your business. Harv Bus Rev. 2003 Feb; 81(2):80-7, 125. PMID: 12577655.
    View in: PubMed
  67. Simon JL, Larson BA, Zusman A, Rosen S. How will the reduction of tariffs and taxes on insecticide- treated bednets affect household purchases? Bull World Health Organ. 2002; 80(11):892-9. PMID: 12481212.
    View in: PubMed
  68. Larson BA, Rosen S. Understanding household demand for indoor air pollution control in developing countries. Soc Sci Med. 2002 Aug; 55(4):571-84. PMID: 12188464.
    View in: PubMed
Sydney's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts
_
BU Co-Authors
_
Similar BU People
_
Same Department